Scotts Miracle Gro Analyst Price Targets - Benzinga

The Scotts Miracle Gro Co

SMGNYSE

Trade with Public

Trade with Public

$49.10

0.080.16%

Últ. Act.: Oct 2, 7:53 PM

$49.10

0.080.16%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

Scotts Miracle Gro Analyst Price Targets

Wall Street analyst price targets and consensus rating for Scotts Miracle Gro (SMG).

Price Target Range — 13 Quarters

Analyst Consensus — 7 Analysts

4Buy

3Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$72Upside to Avg. PT+47.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 5, 2026	Wells Fargo	Chris Carey	PT Cut	Overweight	$77→$60
Sep 29, 2026	Stifel	W. Andrew Carter	PT Cut	Buy	$76→$75
Aug 3, 2026	Stifel	W. Andrew Carter	PT Raise	Buy	$75→$76
Jul 30, 2026	UBS	Peter Grom	PT Raise	Neutral	$70→$78
Jul 30, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$74→$77
Jul 16, 2026	UBS	Peter Grom	PT Raise	Neutral	$63→$70
Jul 8, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$72→$74
Jun 8, 2026	Stifel	W. Andrew Carter	PT Cut	Buy	$76→$75
Apr 8, 2026	Wells Fargo	Chris Carey	PT Cut	Overweight	$75→$72
Mar 26, 2026	JP Morgan	Jeffrey Zekauskas	Downgrade	Overweight→Neutral	$70→$67
Mar 3, 2026	Stifel	W. Andrew Carter	PT Raise	Buy	$70→$79
Jan 29, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$67→$70
Jan 14, 2026	UBS	Peter Grom	PT Raise	Neutral	$61→$66
Nov 6, 2025	UBS	Peter Grom	PT Cut	Neutral	$62→$61
Nov 6, 2025	Stifel	W. Andrew Carter	Upgrade	Hold→Buy	$70
Nov 5, 2025	Jefferies	Jonathan Matuszewski	PT Raise	Buy	$71→$74
Oct 2, 2025	UBS	Peter Grom	PT Cut	Neutral	$68→$62
Sep 25, 2025	Wells Fargo	Chris Carey	PT Cut	Overweight	$75→$67
Aug 4, 2025	Stifel	W. Andrew Carter	PT Cut	Hold	$71→$70
Jul 31, 2025	UBS	Peter Grom	PT Cut	Neutral	$71→$68

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $60

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $77 to $60.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Scotts Miracle Gro, Lowers Price Target to $75

Stifel analyst W. Andrew Carter maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and lowers the price target from $76 to $75.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Scotts Miracle Gro, Raises Price Target to $76

Stifel analyst W. Andrew Carter maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and raises the price target from $75 to $76.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Scotts Miracle Gro, Raises Price Target to $78

UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $70 to $78.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Scotts Miracle Gro, Raises Price Target to $77

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and raises the price target from $74 to $77.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Scotts Miracle Gro, Raises Price Target to $70

UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $63 to $70.

Benzinga Newsdesk